Triple therapy ups response in refractory mantle cell lymphomaFebruary 4, 2018Lymphoma & Plasma Cell Disorders
Background color a dermoscopic clue to cutaneous B-cell lymphomaJanuary 30, 2018Lymphoma & Plasma Cell Disorders
Hodgkin lymphoma survivors are at an increased risk of subsequent ER-negative breast cancerJanuary 30, 2018Breast CancerPatient & Survivor CareLymphoma & Plasma Cell Disorders
Frontline brentuximab vedotin improved Hodgkin lymphoma outcomesJanuary 29, 2018Lymphoma & Plasma Cell Disorders
FDA grants priority review to CAR T-cell therapy for DLBCLJanuary 17, 2018Lymphoma & Plasma Cell Disorders
Denosumab indication now includes multiple myeloma, Amgen announcesJanuary 5, 2018Lymphoma & Plasma Cell Disorders
BTK inhibitor zanubrutinib active in non-Hodgkin lymphomasJanuary 2, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Pemphigus associated with higher risk of hematologic malignanciesDecember 28, 2017Lymphoma & Plasma Cell Disorders
Survival improvements lag for young Hispanic patients with myelomaDecember 27, 2017Lymphoma & Plasma Cell Disorders
Single-agent daratumumab active in smoldering multiple myelomaDecember 26, 2017Lymphoma & Plasma Cell Disorders
Study identifies predictors of acquired von Willebrand diseaseDecember 26, 2017Lymphoma & Plasma Cell Disorders
VIDEO - New lymphoma drug approvals: Clinical use, future directionsDecember 14, 2017Lymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma